REIT-Managed OZ Fund Pays $48M For Somerville Site, Plans Life Sciences Building

Google Maps
Columbia Property Trust Plans To Build A Life Sciences Facility At Its Newest Purchase, A $48M, 1.2-Acre Site In Somerville.

Columbia Property Trust is seeking its own life sciences footprint in Boston’s suburbs, buying a $48M opportunity zone site not far from Cambridge’s Kendall Square.

A fund controlled by the New York-based REIT purchased a 1.2-acre plot known as Boynton Gateway in Somerville, JLL Capital Markets, which brokered the deal, announced Monday.

In addition to the land, which was acquired from a group of undisclosed sellers, the fund purchased a leasehold interest in an adjacent, 252-space parking garage. Columbia, which trades on the New York Stock Exchange under the ticker symbol CXP, plans to develop a life sciences building on the combined parcels, which are at 64 and 68 Webster Ave., 495, 497, 513 and 517 Columbia St. and 6 Beach Ave., with the garage at 481 Columbia.

The brokerage also arranged $24M in acquisition financing for the purchase from the Bank of New England. JLL said CXP intends to build a life sciences facility at the site near the incoming MBTA Green Line Union Square station slated to be completed next winter.

A representative for CXP confirmed the sale closed last week but declined to comment further.

Boynton Gateway sits just over a mile away from Kendall Square, the life sciences hub where office vacancies sit at 3.2%, according to Cushman & Wakefield’s Q3 2020 office report. The sellers and the owner of the garage were not disclosed by JLL, but public records show five different trusts own the various sites.

The assets were purchased by the Normandy Opportunity Zone Fund LP, a fund advised by Columbia Real Estate Management. CXP closed on the purchase of Normandy Real Estate Partners earlier this year in a $100M cash and stock deal, and it took control of the management in the QOF, as well as its 2% equity stake in the fund. Bisnow previously reported the fund was targeting a $250M capital raise.

The opportunity zone program, which allows investors in QOFs to bypass capital gains taxes if the funds improve or develop assets in designated census tracts and hold them for 10 years, has come under scrutiny for hastening gentrification and not helping the areas that need it. Not only could the investors in Normandy QOF see their capital gains go untaxed if they hold the investment for the next decade, but any company that moves to the development could see its own tax benefit from the opportunity zone program — assuming it lives on, which is not guaranteed.

Continue reading this story with a free account

Log in or register
Related Topics: Life Sciences
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Philly Life Sciences Players Say Sluggish Market Needs More VC, State Funding

Developer Plans 595 Apartments At Woburn Transit Center

Boston City Council Votes To Eliminate Parking Minimums For New Housing Development

Lack Of Available Medical Office Space In Boston Forces Tenants To Get Creative

Fenway Center Apartment Complex Trades For $193M: The Boston Deal Sheet

How The Investors Upgrading Boston's Old Office Towers Are Luring New Tenants

AI Helps Drive New Demand For Lab Buildings, But Property Values Remain 'Depressed'

Lender Takes Control Of Vacant Somerville Lab Building Following Failed Sale

Kraft Group Seeks To Build $16B Data Center Campus: The Boston Deal Sheet

Wu Proposes Loosening Affordable Housing Mandates To Spur Development

Revere Housing Authority Seeks Zoning Change For 1,700-Unit Redevelopment

Raleigh-Durham's Growth Story Is Moving Beyond Life Sciences